Debt to Equity Ratio Chart

View Debt to Equity Ratio for SIGA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.0027
March 31, 2026 0.0042
December 31, 2025 0.004
September 30, 2025 0.0043
June 30, 2025 0.0051
March 31, 2025 0.0058
December 31, 2024 0.0062
September 30, 2024 0.0091
June 30, 2024 0.0097
March 31, 2024 0.0079
December 31, 2023 0.0074
September 30, 2023 0.0133
June 30, 2023 0.0188
March 31, 2023 0.0152
December 31, 2022 0.0119
September 30, 2022 0.0158
June 30, 2022 0.0165
March 31, 2022 0.0148
December 31, 2021 0.0147
September 30, 2021 0.0262
June 30, 2021 0.0243
March 31, 2021 0.0179
December 31, 2020 0.0181
September 30, 2020 0.0216
June 30, 2020 0.0275
Date Value
March 31, 2020 0.0307
December 31, 2019 0.8474
September 30, 2019 0.7954
June 30, 2019 0.7818
March 31, 2019 0.7227
December 31, 2018 0.7341
September 30, 2018 1.418
June 30, 2018 -0.2147
March 31, 2018 -0.2156
December 31, 2017 -0.2199
September 30, 2017 -0.2235
June 30, 2017 -0.2267
March 31, 2017 -0.2285
December 31, 2016 -0.2316
September 30, 2016 -0.2991
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 -0.0081
September 30, 2014 -0.0109
June 30, 2014 0.2573
March 31, 2014 0.2489

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.022
Corcept Therapeutics, Inc. 0.0133
Veru, Inc. 0.0945
Johnson & Johnson 0.5771
Eli Lilly & Co. 1.621